MoodMark is a family of products with the potential to revolutionize diagnosis, treatment, and drug discovery for depression.

It is based on a patented platform aiding in the diagnosis of depression, informing its treatment, and guiding discovery of novel antidepressants.

TheMoodMark Biomarkers will be used to identify appropriate subjects for the purpose of enriching clinical trials and impacting patient treatment decisions.